Our Products
HepBQuin
Form500 IU/5 ml solution for IM Injection
ACTIVE INGREDIENTHuman Hepatitis B Immunoglobulin
COMMERCIAL SHAPE1 vial/box
Therapeutic Indications:
Hepatitis B Immunoglobulin is indicated in the conditions described below for protection purposes when there is a high risk of acute exposure to hepatitis B.
- Risk involving encounter with blood or body secretions involving or at high risk of HBsAg, in the following situations in case of domestic contact with babies born from an HBsAg positive mother and a person who has had acute hepatitis B,
- Risky encounter with blood containing HBsAg, parenteral (needle sting, bite, deep injury) or direct contact of mucosal surfaces (accidental eye-to-oral mucosa), oral swallowing (accidental drinking-pipetting), blood, serum or plasma taking,
- Perinatally, the baby is born (by normal or cesarean) from the HBsAg positive mother (regardless of whether it is HBeAg positive or negative)
- In the presence of an HBsAg positive sexual partner,
- In the presence of someone who has had an acute hepatitis B infection in the house, babies younger than 12 months who have not been vaccinated before and older than 12 months with risky contact with blood,
For these uses; the person should not have been previously vaccinated with hepatitis B vaccine.
- The vaccine response should also be taken into account when evaluating health care workers after risky contact. People who have not produced an antibody response despite being vaccinated should be evaluated as unvaccinated.
- It is indicated in liver transplant recipients who have a recurrent risk after liver transplantation.



